Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Cidara Therapeutics’ main value driver, CD388, recently achieved an impressive 76% protection in its Phase 2b trials. See why ...

“The positive results from this confirmatory patient study represent an important step in the development of the Xolair® biosimilar candidate. We look forward to working with our partners to increase ...

Nascent U.S. CCA Designs Head For Growing Export Market is available to both Aviation Week & Space Technology and AWIN subscribers. Subscribe now to read this content, plus receive critical analysis ...

Starton Therapeutics Inc., a clinical-stage biotechnology company, has entered into a collaboration agreement with Bend Bioscience.

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Alvotech is also developing AVT29, a proposed biosimilar to Eylea® HD, a higher dose (aflibercept 8 mg) aflibercept. Advanz has licensed the distribution rights from Alvotech for both biosimilar ...

FDI inflows to Romania reached EUR 5.7 billion, reflecting a 14% decrease from EUR 6.6 billion in 2023, according to ...

A prominent marketer in the consumer healthcare industry, Ed Round has joined Cornerstone Design and Marketing in the new ...